Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Employees
5,900
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart MEDPACE-HOLDINGS-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
352.22USD
Average target price
347.92USD
Spread / Average Target
-1.22%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MEDP Stock
  4. ETFs Medpace Holdings, Inc.